Clindamycin for Streptococcal Infection with Ampicillin and Azithromycin Allergy
For a patient with streptococcal infection who is allergic to both ampicillin (a penicillin) and azithromycin (a macrolide), clindamycin is the recommended antibiotic. 1
Rationale for Clindamycin
The 2013 IDSA guideline explicitly lists clindamycin as an alternative for patients with penicillin allergy, with dosing of 7 mg/kg per dose three times daily (maximum 300 mg per dose) for 10 days in children, or 300-400 mg three times daily for adults 1. This recommendation carries a strong recommendation with moderate quality evidence 1.
Why Not Other Options?
Cephalosporins (first-generation): While typically recommended for penicillin-allergic patients, they should be avoided in patients with immediate hypersensitivity (Type I) reactions to penicillin 1, 2. Since you mention ampicillin allergy without specifying the type, if there's any history of anaphylaxis, urticaria, or immediate reaction, cephalosporins carry cross-reactivity risk (approximately 1-3% with first-generation agents).
Azithromycin/Macrolides: Already excluded due to patient's azithromycin allergy. Additionally, the FDA label notes that some strains are resistant to azithromycin, and susceptibility testing should be performed 3. Recent evidence shows azithromycin has inferior efficacy with higher recurrence rates 4.
Clarithromycin: Another macrolide with potential cross-reactivity given the azithromycin allergy.
Clindamycin Advantages
Clindamycin has approximately 90% activity against S. pneumoniae and excellent coverage for Group A Streptococcus 2. It's bacteriostatic but highly effective for streptococcal pharyngitis and skin/soft tissue infections 5, 6.
Dosing Specifics
Adults: 300-400 mg orally three times daily for 10 days 1, 6
Children: 20 mg/kg/day divided into three doses (maximum 300 mg per dose) for 10 days 1
Severe infections: 600 mg IV every 8 hours may be used 5
Important Caveats
Duration matters: The full 10-day course is essential for streptococcal eradication and rheumatic fever prevention 1, 7.
Resistance monitoring: While clindamycin resistance in Group A Streptococcus is uncommon in the United States, there's potential for cross-resistance with erythromycin-resistant strains and inducible resistance 5, 6.
C. difficile risk: Like all antibiotics, clindamycin carries risk of Clostridioides difficile infection. Counsel patients to report severe diarrhea 3.
Allergy clarification: If the ampicillin allergy was a non-severe delayed reaction (e.g., mild rash days after starting), first-generation cephalosporins like cephalexin could be considered as they have lower cross-reactivity risk 1, 8. However, clindamycin remains the safest choice when allergy history is uncertain.
Alternative if Clindamycin Unavailable
If clindamycin is contraindicated or unavailable, consider:
- Fluoroquinolones (levofloxacin, moxifloxacin) for adults only - though these are broader spectrum and should be reserved 2
- TMP-SMX has limited efficacy (20-25% bacterial failure rate) but may be used if no other options exist 2
The bottom line: Clindamycin 300-400 mg three times daily for 10 days is your answer for this dual-allergic patient with streptococcal infection.